Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVAC-TP: Enoxaparin thromboprophylaxis in pediatric COVID-19
NCT04354155Phase 2Completed
- Sponsor
- Johns Hopkins All Children's Hospital
- Start
- Jun 2020
- Primary completion
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of enoxaparin in coronavirus disease 2019 (COVID-19), sponsored by Johns Hopkins All Children's Hospital. Started Jun 2020; status: completed.
02
Drugs
enoxaparin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04354155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04354155.